Adults 18 to 75, any sex, with Alcoholism or Substance-related Disorders. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Standard Ethanol Content Units (SECs) BaselinePrimary· 30 days prior to Baseline
The Timeline Follow-Back (TLFB) calendar was used to assess retrospective self-report of alcohol in the 30 days prior to baseline. Amount of alcohol consumption was converted to standard ethanol content units (SECs; or standard drinks) equivalent to 0.5 oz. of ethanol. This measure represents ALL standard drinks consumed within the stated time period.
Group
Value
95% CI
GMI - Standard Ethanol Content Units (SECs) at Baseline
179.9
57.4 – 240.6
LSEG - Standard Ethanol Content Units (SECs) at Baseline
190.1
68.5 – 244.7
Standard Ethanol Content Units (SECs) at 1 MonthPrimary· 1 month
The 1-month follow-up was conducted 30 days after day 1 of the treatment group. The Timeline Follow-Back (TLFB) calendar was used to assess retrospective self-report of alcohol in the 30 days prior to 1-month follow-up. Amount of alcohol consumption was converted to standard ethanol content units (SECs; or standard drinks) equivalent to 0.5 oz. of ethanol. This measure represents ALL standard drinks consumed within the stated time period.
Group
Value
95% CI
GMI - Standard Ethanol Content Units (SECs) at 1 Month
44.9
0.0 – 28.2
LSEG - Standard Ethanol Content Units (SECs) at 1 Month
36.9
0.0 – 51.2
Standard Ethanol Content Units (SECs) at 3 MonthsPrimary· 3 months
The 3-month follow-up was conducted 60 days after the 1-month follow-up. The Timeline Follow-Back (TLFB) calendar was used to assess retrospective self-report of alcohol in the 60 days prior to 3-month follow-up. Amount of alcohol consumption was converted to standard ethanol content units (SECs; or standard drinks) equivalent to 0.5 oz. of ethanol. This measure represents ALL standard drinks consumed within the stated time period.
Group
Value
95% CI
GMI - Standard Ethanol Content Units (SECs) at 3 Months
50.1
0.0 – 54.4
LSEG - Standard Ethanol Content Units (SECs) at 3 Months
37.7
0.0 – 44.5
Standard Ethanol Content Units (SECs) at 6 MonthsPrimary· 6 months
The 6-month follow-up was conducted 90 days after the 3-month follow-up. The Timeline Follow-Back (TLFB) calendar was used to assess retrospective self-report of alcohol in the 90 days prior to 6-month follow-up. Amount of alcohol consumption was converted to standard ethanol content units (SECs; or standard drinks) equivalent to 0.5 oz. of ethanol. This measure represents ALL standard drinks consumed within the stated time period.
Group
Value
95% CI
GMI - Standard Ethanol Content Units (SECs) at 6 Months
96.5
0.0 – 89.7
LSEG - Standard Ethanol Content Units (SECs) at 6 Months
66.9
0.0 – 104.4
Peak SEC at BaselinePrimary· 30 days prior to Baseline
The Timeline Follow-Back (TLFB) calendar was used to assess retrospective self-report of alcohol in the 30 days prior to baseline. Amount of alcohol consumption was converted to standard ethanol content units (SECs; or standard drinks) equivalent to 0.5 oz. of ethanol. This measure represents the most standard drinks consumed in a single day within the stated time period.
Group
Value
95% CI
GMI - Peak SEC at Baseline
21.0
12.0 – 25.6
LSEG - Peak SEC at Baseline
19.1
10.6 – 25.6
Peak SEC at 1 MonthPrimary· 1 month
The 1-month follow-up was conducted 30 days after day 1 of the treatment group. The Timeline Follow-Back (TLFB) calendar was used to assess retrospective self-report of alcohol in the 30 days prior to 1-month follow-up. Amount of alcohol consumption was converted to standard ethanol content units (SECs; or standard drinks) equivalent to 0.5 oz. of ethanol. This measure represents the most standard drinks consumed on a single day within the stated time period.
Group
Value
95% CI
GMI - Peak SEC at 1 Month
4.8
0.0 – 6.4
LSEG - Peak SEC at 1 Month
4.5
0.0 – 7.4
Peak SEC at 3 MonthsPrimary· 3 months
The 3-month follow-up was conducted 60 days after the 1-month follow-up. The Timeline Follow-Back (TLFB) calendar was used to assess retrospective self-report of alcohol in the 60 days prior to 3-month follow-up. Amount of alcohol consumption was converted to standard ethanol content units (SECs; or standard drinks) equivalent to 0.5 oz. of ethanol. This measure represents the most standard drinks consumed on a single day within the stated time period.
Group
Value
95% CI
GMI - Peak SEC at 3 Months
9.8
0.0 – 13.0
LSEG - Peak SEC at 3 Months
5.9
0.0 – 8.4
Peak SEC at 6 MonthsPrimary· 6 months
The 6-month follow-up was conducted 90 days after the 3-month follow-up. The Timeline Follow-Back (TLFB) calendar was used to assess retrospective self-report of alcohol in the 90 days prior to 6-month follow-up. Amount of alcohol consumption was converted to standard ethanol content units (SECs; or standard drinks) equivalent to 0.5 oz. of ethanol. This measure represents the most standard drinks consumed on a single day within the stated time period.
Group
Value
95% CI
GMI - Peak SEC at 6 Months
10.3
0.0 – 15.8
LSEG - Peak SEC at 6 Months
7.2
0.0 – 10.8
Alcohol Drink Days at BaselinePrimary· 30 days prior to Baseline
The Timeline Follow-Back (TLFB) calendar was used to assess retrospective self-report of alcohol in the 30 days prior to Baseline. This measure represents the number of days any alcohol was consumed within the stated time period.
Group
Value
95% CI
GMI -Alcohol Drink Days at Baseline
13.3
6.0 – 21.0
LSEG - Alcohol Drink Days at Baseline
14.8
8.0 – 21.0
Alcohol Drink Days at 1 MonthPrimary· 1 month
The Timeline Follow-Back (TLFB) calendar was used to assess retrospective self-report of alcohol in the 30 days after day 1 of the treatment group. This measure represents the number of days any alcohol was consumed within the stated time period.
Group
Value
95% CI
GMI - Alcohol Drink Days at 1 Month
4.6
0.0 – 4.0
LSEG - Alcohol Drink Days at 1 Month
5.5
0.0 – 5.0
Alcohol Drink Days at 3 MonthsPrimary· 3 months
The Timeline Follow-Back (TLFB) calendar was used to assess retrospective self-report of alcohol in the 60 days prior to 3-month follow-up. This measure represents the number of days any alcohol was consumed within the stated time period.
Group
Value
95% CI
GMI - Alcohol Drink Days at 3 Months
6.2
0.0 – 9.5
LSEG - Alcohol Drink Days at 3 Months
6.6
0.0 – 12.0
Alcohol Drink Days at 6 MonthsPrimary· 6 months
The Timeline Follow-Back (TLFB) calendar was used to assess retrospective self-report of alcohol in the 90 days prior to 6-month follow-up. This measure represents the number of days any alcohol was consumed within the stated time period.
Group
Value
95% CI
GMI - Alcohol Drink Days at 6 Months
8.3
0.0 – 13.7
LSEG - Alcohol Drink Days at 6 Months
8.3
0.0 – 16.0
Sponsor's own description
Homeless Veterans with substance use disorders (SUDs) are a major group served by VA and are heavily represented in VA housing. VA recently adopted a 'Housing First' approach emphasizing rapid housing placement to initiate recovery without requiring sobriety and will necessitate SUD interventions that are efficient and easily layered onto existing services. The proposed study will investigate the effectiveness, implementation process, and cost estimate of Group Motivational Interviewing (GMI) for Veterans with SUDs in VA housing (Housing Urban Development-VA Support Housing \[HUD-VASH\] and Grant and per Diem \[GPD\]). Outcomes will be assessed at multiple time points using a multi-modal approach. The ultimate goal of this research is to establish the basis of a GMI dissemination and implementation course of action for highly vulnerable homeless Veterans in VA housing for achieving their greatest success in attaining housing stability.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06676059 — SMART-r: Substance Monitoring and Active Relapse Tracking Repository
· recruiting
NCT06493773 — Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled Trial
· NA
· recruiting
NCT07216872 — Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use
· NA
· recruiting
NCT07305701 — Cohort Study on Medical Students' Mental Health
· recruiting
NCT06415721 — Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
· NA
· recruiting
Other VA Office of Research and Development trials
Trials by the same sponsor.
NCT07456150 — Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care
· Phase 1
· not yet recruiting
NCT06746727 — The Development of a Transdiagnostic Intervention to Improve Social Functioning and Intimate Relationships Among Veteran
· NA
· not yet recruiting
NCT07362576 — Perinatal Peer Support for Veterans With Serious Mental Illness
· NA
· not yet recruiting
NCT06766331 — Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
· NA
· not yet recruiting
NCT07397195 — ACT for Veterans With IBD and Mental Health Challenges
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by VA Office of Research and Development
Last refreshed: 27 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02233738.